We are live on ! Find out more

546 hedge funds and large institutions have $6.78B invested in Chemours in 2018 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 155 increasing their positions, 181 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 67

2% more funds holding

Funds holding: 537546 (+9)

0.02% more ownership

Funds ownership: 76.72%76.75% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

5% less capital invested

Capital invested by funds: $7.11B → $6.78B (-$325M)

14% less repeat investments, than reductions

Existing positions increased: 155 | Existing positions reduced: 181

17% less call options, than puts

Call options by funds: $61.7M | Put options by funds: $73.9M

Holders
546
Holders Change
+9
Holders Change %
+1.68%
% of All Funds
12.51%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
81
Increased
155
Reduced
181
Closed
67
Calls
$61.7M
Puts
$73.9M
Net Calls
-$12.2M
Net Calls Change
-$5.54M

CC Hedge Fund Activity: Q1 2018 in Review

546 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2018, worth a combined $6.78B — down 4.6% from $7.11B a quarter earlier.

Buyers outnumbered sellers: 81 funds opened new CC positions and 67 closed out — a net gain of 14 holders — while 155 added to existing stakes and 181 trimmed.

The largest buyer was Iridian Asset Management, opening a new position worth an estimated $227M. The largest seller was TIAA CREF Investment Management, cutting an estimated $116M.

  • 546 institutional investors held Chemours (CC) as of Q1 2018, up from 537 in Q4 2017.
  • Funds reported $6.78B of Chemours stock for Q1 2018, down 4.6% quarter-over-quarter.
  • 81 funds opened new Chemours positions in Q1 2018 and 67 closed out, a net change of +14 holders.
  • The largest Chemours buyer in Q1 2018 was Iridian Asset Management, an estimated $227M added.
  • The largest Chemours seller in Q1 2018 was TIAA CREF Investment Management, an estimated $116M sold.

Based on aggregated 13F filings for Q1 2018.